In an important step to expand access to world class oncology services, the Burjeel Cancer Institute (BCI), one of the largest cancer care networks of the EAU, has announced strategic collaborations with three renowned institutions worldwide: the European Institute of Oncology (IEO), the Global Health Hospital of Children of Children (Chop) and SJD Barcelona. These associations are aimed at redefining oncological attention in the region advancing clinical services, research, education and personalized oncology.
BCI serves more than 5,000 patients each year and provides custom care of 360 degrees, from diagnosis to survival programs. Its network extends through all the EAU, including key locations in Abu Dhabi, Al Ain, Dubai, Sharjah and Dhafra, ensuring access to integral and compassionate cancer care at all ages.
These new collaborations will take advantage of teleconsultation and remote technologies of patient monitoring, the second opinions of facilitation of international experts and establish visit programs to allow a deeper knowledge exchange and improve local capacities.
Improvement of pediatric cancer care
The collaboration of the Children’s Hospital of Philadelphia (Chop) will improve the attention of pediatric cancer and strengthen the abilities in advanced diagnoses, remote consultations and second multidisciplinary opinions. Chop’s visit programs will support the exchange of knowledge in subspecialized pediatric oncology.
Mrs. Madeline Bell – President and Executive Director (CEO) of the Children’s Hospital of Philadelphia (Chop), said: “We are excited to collaborate with BCI to advance the care of pediatric cancer through shared experience. Medical care teams and support families facing childhood cancer.”
The association with SJD Barcelona Children’s Hospital is scheduled to further increase BCI capabilities in the integral care of childhood cancer. The collaboration will offer continuous remote support and medical orientation, partly for rare and complex pediatric cases.
Dr. Manel del Castillo Rey-Chief Executive Official (CEO) SJD Barcelona Children’s Hospital, commented: “Our collaboration with BCI provides a framework for sharing specialized knowledge and cases of complex geography of boxes.
Integrating global experience
In association with the European Institute of Oncology (IEO), BCI will focus on strengthening cancer care in the EAU through development, training and education of clinical and scientific research programs for health professionals and high -level clinics. The collaboration will also support the creation of a distinguished network of visiting teachers, capacity construction initiatives for nurses and pharmacists, and the establishment of a strategic advisory board for BCI.
Ing. Mauro Melis-Chief Executive Officer IEO & Cardiological Center Monzino, Said, “Our Partnership with Burjeeel Cancer Institute Reflects A Shared Commitment To Elevating Standards In Cancer Care. Aimal Bulating, and Aimacachalling, and Aimacachanging, and Aimacachalling, and Aimacachalling.
Advance diagnosis tests for cancer
In addition to these collaborations, Burjel Cancer Institute also joined Abbvie Biopharmaceuticals to advance a personalized medicine approach in cancer care. The collaboration aims to support the adoption and access to the latest test techniques to improve the diagnosis and treatment of patients with types of cancer cancer, including ovarian, pulmonary and colorectal malignments.
As part of this initiative, The Anatomical Pathology Laboratory Lead By Dr. Rawia Mubarak Will Introduction A Test For The First Time In The Region for Platinum-Resistant Ovaraian Cancer, which Will Help Idelify Patients Who May Benef Benit From Emerging Targeted Therapies-Offering A More Custom Pers Renedwed Hope for Better Hope for Better for Better for Better for Better for Better for Better for Better for Better for Better for Better for Better for Better for Better for Better for Better for better for better for better forward.
Mr. Mohammad Aboubakr Abdulgawad Mohammad – General Manager of Abbvie Pharmaceuticals, said: “Through our collaboration with the Burjeel Cancer Institute, we are proud to present this advanced test in the EU individual.
Prof. Humaid Al Shamsi, CEO or the Burjel Cancer Institute commented: “These global associations are a fundamental step in our mission of providing care for world class cancer to the region. By aligning with the somemoms of the most prestigious institutions worldwide, ecosystems that prioritize quality, access and innovation for each patient to whom we serve.”
These associations underline BCI’s strategic vision to not only expand their clinical abilities, but also serve as a regional center for knowledge, innovation and excellence in oncology.
Follow Emirates 24 | 7 on Google News.
